![](/img/cover-not-exists.png)
Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: An Industry Perspective: The ISPOR Drug Cost Task Force Report—Part V
Jack M. Mycka, Renato Dellamano, Eugene Mick Kolassa, Michael Wonder, Sabyasachi Ghosh, Joel W. Hay, Jim SmeedingVolume:
13
Year:
2010
Language:
english
Pages:
3
DOI:
10.1111/j.1524-4733.2009.00664.x
File:
PDF, 58 KB
english, 2010